Immunohistochemical analysis of cell proliferation and suppression of ameloblastoma with special reference to plexiform and follicular ameloblastoma

被引:11
作者
Hirayama, T
Hamada, T
Hasui, K
Semba, I
Murata, F
Sugihara, K
机构
[1] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Maxillofacial Diagnost & Surg Sci, Field Oral & Maxillofacial Rehabil, Kagoshima 8908544, Japan
[2] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Struct Cell Biol, Field Neuromusculoskeletal Disorder, Kagoshima, Japan
[3] Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oncol, Dept Oral Pathol, Kagoshima, Japan
关键词
ameloblastoma; PCNA; Ki-67; topoisomerase Il alpha; p53;
D O I
10.1267/ahc.37.391
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
To understand proliferation and suppression in ameloblastoma that exhibit locally invasive growth and recur clinically, the expression of proliferating cell nuclear antigen (PCNA), Ki-67 antigen, topoisomerase 11 alpha, p53 and p21 proteins were analyzed with immunohistochemistry. Sections of archival ameloblastoma tissues were used (16 plexiform and 14 follicular types). Each antigen was labeled by the polymer method with optimal antigen retrieval. The plexiform type exhibited higher expression of PCNA, Ki-67 and topoisomerase 11 alpha antigens than the follicular type. Expression of PCNA correlated significantly with that of the Ki-67 antigen. The plexiform type also exhibited greater expression of p53 and p21 proteins than the follicular type. Expression of p53 protein correlated significantly with that of p21, PCNA, Ki-67 antigen and topoisomerase 11 alpha. Expression of p21 protein did not correlate with that of the proliferation-related antigens. These findings suggest that the plexiform ameloblastoma has higher proliferating activity and malignant potentiality as neoplastic cells than the follicular ameloblastoma.
引用
收藏
页码:391 / 398
页数:8
相关论文
共 30 条
[1]   CYCLIN PCNA IS THE AUXILIARY PROTEIN OF DNA POLYMERASE-DELTA [J].
BRAVO, R ;
FRANK, R ;
BLUNDELL, PA ;
MACDONALDBRAVO, H .
NATURE, 1987, 326 (6112) :515-517
[2]  
Funaoka K, 1996, ORAL ONCOL, V32B, P328
[3]  
GERDES J, 1984, J IMMUNOL, V133, P1710
[4]   PRODUCTION OF A MOUSE MONOCLONAL-ANTIBODY REACTIVE WITH A HUMAN NUCLEAR ANTIGEN ASSOCIATED WITH CELL-PROLIFERATION [J].
GERDES, J ;
SCHWAB, U ;
LEMKE, H ;
STEIN, H .
INTERNATIONAL JOURNAL OF CANCER, 1983, 31 (01) :13-20
[5]  
GERDES J, 1991, AM J PATHOL, V138, P867
[6]  
HAYASHI K, 1995, J JPN STOMATOL SOC, V44, P7
[7]  
IWAMOTO H, 1998, J JPN STOMATOL SOC, V47, P471
[8]  
KIM J, 1994, ORAL ONCOL, V30B, P126
[9]   Possible factors related to phenotype change from adenocarcinoma to squamous cell carcinoma [J].
Kinjo, T ;
Kamiyama, K ;
Chinen, K ;
Arasaki, A ;
Iwamasa, T .
ACTA HISTOCHEMICA ET CYTOCHEMICA, 2004, 37 (01) :7-14
[10]  
KRAMER IRH, 1992, WHO HISTOLOGICAL TYP, P11